These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 70292)

  • 21. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
    Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
    IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus].
    De la Barrera S; Fejes M; Riera NE; Scaglione C; Pérez Blanco R; de Bracco MM
    Rev Argent Microbiol; 1985; 17(3):137-43. PubMed ID: 2829276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology.
    Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L
    J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibodies in three populations of Burkitt's lymphoma patients.
    Vainio E; Lenoir GM; Franklin RM
    Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Epstein-Barr virus-encoded glycoprotein gp 110 (BALF 4) can serve as a target for antibody-dependent cell-mediated cytotoxicity (ADCC).
    Jilg W; Bogedain C; Mairhofer H; Gu SY; Wolf H
    Virology; 1994 Aug; 202(2):974-7. PubMed ID: 8030258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP).
    Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E
    Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiology of endemic Burkitt's lymphoma.
    Olweny CL
    IARC Sci Publ; 1984; (63):647-53. PubMed ID: 6100285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
    Magrath I; Henle W; Owor R; Olweny C
    N Engl J Med; 1975 Mar; 292(12):621-3. PubMed ID: 163432
    [No Abstract]   [Full Text] [Related]  

  • 33. Burkitt's lymphoma - a human tumor model system for immunological studies.
    Gunvén P
    Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
    Pearson G; Klein G; Henle G; Henle W; Clifford P
    J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in antibodies to Epstein-Barr virus-associated antigens with the development of Burkitt's lymphoma.
    Magrath IT; Henle W
    IARC Sci Publ (1971); 1975; (11 Pt 2):275-81. PubMed ID: 191371
    [No Abstract]   [Full Text] [Related]  

  • 36. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.
    Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R
    J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Epstein-Barr virus and American Burkitt's lymphoma.
    Easton JM; Ablashi DV; Levine PH; Armstrong GR
    IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
    Pearson GR; Orr TW
    J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 40. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.